Hormone Replacement Therapy (HRT) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Hormone Replacement Therapy Market
The hormone replacement therapy market size was valued at USD 15.94 billion in 2023, and the market is now projected to grow from USD 16.91 billion in 2024 to USD 27.52 billion by 2032, exhibiting a CAGR of 6.3% during the forecast period of 2024-2032.
Pandemic negatively impacted the hormone replacement therapy market growth due to an international shortage of therapy elements, inflicting distress for pre and post-menopausal women. The closure of healthcare facilities throughout the pandemic also negatively affected the sales of those merchandise, affecting the prognosis of sufferers with hormonal disorders. Despite robust income declines in FY 2020 for principal agencies, the call for these cures and the return to everyday healthcare visits have allowed the market to return to pre-pandemic growth levels.
Menopause is a commonplace gynecological disease in ladies, even as growth hormone is a rare endocrine sickness inflicting symptoms like decreased power tiers, insulin resistance, lipid abnormalities, and occasional bodily activities in adults. The prevalence of increase hormone sickness is excessive in sufferers with Langerhans cellular histiocytosis, which triggers diabetes insipidus, leading to increase hormone deficiency. The rise in increase hormone deficiency occurrence in adults has caused expanded adoption of therapies, which include GHRT, which has low aspect effects and improves maximum alterations in GH deficiency with appropriate dosage. The upward thrust in menopausal conditions and boom deficiency from diabetes insipidus is likewise riding the development of new products and a successful launch technique, boosting marketplace growth in the forecast duration.
The growing demand for hormone substitute in developing nations and extended recognition approximately hormone disorders are driving pharmaceutical companies to release advanced drugs within the worldwide market. Menopause and hormone deficiency issues also are using the development of combination remedy merchandise. The consciousness on personalized remedy and precision hormone remedy is rising as a trend, with healthcare providers tailoring treatment regimens to character patient needs. The preference for transdermal estrogen management over oral ones reduces dangers related to venous thromboembolism, selling symptom-free menopause for women.
Comprehensive Analysis of Hormone Replacement Therapy Market
The hormone replacement market is divided into estrogen and combinations therapy, growth, thyroid, and testosterone therapy. Estrogen and combination therapy is expected to dominate market growth due to increased awareness of menopause symptoms, improved therapies, and drug availability. Growth hormone replacement therapy is expected to contribute to a strong CAGR due to the rise in prevalence of growth hormone deficiencies in key countries. Testosterone hormone replacement therapy is expected to witness steady growth due to new drugs for hypogonadism in men and recent FDA approvals. The thyroid hormone replacement therapy segment is also developing due to increased prevalence of thyroid disorders. The market is segmented into menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency. Menopause holds the largest market share due to women suffering from debilitating symptoms. Hypothyroidism is the second-largest market share due to the rise in thyroid disease prevalence. The oral route of administration holds the largest market share due to increased adoption of oral drugs and large production of oral consumption drugs by key players. The transdermal segment is expected to register a significant CAGR due to new gel formation therapies. The market is estimated to reach USD 4,500.0 million by 2025.
The North America region lead the hormone replacement therapy market share by benefitting a market size of USD 8.35 billion in 2023 due to rise in menopause and growth hormone deficiency disorders incidence and excessive recognition among sufferers aged 35 and above. The US sees approximately 6,000 adults recognized with hyposomatotropism yearly. Increased regulatory approvals, advanced cures, and strong healthcare expenditure are contributing to the place's increase, with advanced merchandise and sturdy healthcare expenditure similarly boosting the adoption of those cures.
The market is dominated by Novo Nordisk A/S and Pfizer Inc. due to their diverse product portfolio. Novo Nordisk is the most profitable due to its popular product, Norditropin. The market is expected to grow due to its significant global upscale. Other key players include AbbVie's, Merk KGaA, Endo International plc, Allergan plc, Eli Lilly and Company, Mithra Pharmaceuticals, and Amgen.
In June 2023, Pfizer Inc. Reintroduced DI-JAVEE, a hormone remedy for menopause containing estrogen, with improved packaging.
Segmentation Table
ATTRIBUTE
DETAILS
Study Period
2019-2032
Base Year
2023
Estimated Year
2024
Forecast Period
2024-2032
Historical Period
2019-2022
Unit
Value (USD billion)
Growth RateCAGR of 6.3% from 2024-2032
By Therapy Type
Estrogen and Combinations Replacement Therapy
Thyroid Hormone Replacement Therapy
Growth Hormone Replacement Therapy
Testosterone Hormone Replacement Therapy
By Indication
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
By Route of Administration
Oral
Transdermal
Parenteral
By Distribution Channel
Hospitals Pharmacies
Retail Pharmacies & Drug Stores
Online Pharmacies
By Geography
North America (By Therapy Type, By Indication, By Route of Administration, By Distribution Channel, and By Country)
- U.S.
- Canada
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- China
- Japan
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of the Middle East and Africa
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Pipeline Analysis, By Key Players
- 4.2. Key Industry Developments - Mergers, Acquisitions, and Collaborations
- 4.3. New Product Launches, By Key Players
- 4.4. Impact of COVID-19 on the Global Hormone Replacement Therapy Market
- 5. Global Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Therapy Type
- 5.1.1. Estrogen and Combinations Replacement Therapy
- 5.1.2. Thyroid Hormone Replacement Therapy
- 5.1.3. Growth Hormone Replacement Therapy
- 5.1.4. Testosterone Hormone Replacement Therapy
- 5.2. Market Analysis, Insights and Forecast – By Indication
- 5.2.1. Menopause
- 5.2.2. Hypothyroidism
- 5.2.3. Male hypogonadism
- 5.2.4. Growth hormone deficiency
- 5.3. Market Analysis, Insights and Forecast – By Route of Administration
- 5.3.1. Oral
- 5.3.2. Transdermal
- 5.3.3. Parenteral
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospitals Pharmacies
- 5.4.2. Retail Pharmacies & Drug Stores
- 5.4.3. Online Pharmacies
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Therapy Type
- 6.1.1. Estrogen and Combinations Replacement Therapy
- 6.1.2. Thyroid Hormone Replacement Therapy
- 6.1.3. Growth Hormone Replacement Therapy
- 6.1.4. Testosterone Hormone Replacement Therapy
- 6.2. Market Analysis, Insights and Forecast – By Indication
- 6.2.1. Menopause
- 6.2.2. Hypothyroidism
- 6.2.3. Male hypogonadism
- 6.2.4. Growth hormone deficiency
- 6.3. Market Analysis, Insights and Forecast – By Route of Administration
- 6.3.1. Oral
- 6.3.2. Transdermal
- 6.3.3. Parenteral
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospitals Pharmacies
- 6.4.2. Retail Pharmacies & Drug Stores
- 6.4.3. Online Pharmacies
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Therapy Type
- 7.1.1. Estrogen and Combinations Replacement Therapy
- 7.1.2. Thyroid Hormone Replacement Therapy
- 7.1.3. Growth Hormone Replacement Therapy
- 7.1.4. Testosterone Hormone Replacement Therapy
- 7.2. Market Analysis, Insights and Forecast – By Indication
- 7.2.1. Menopause
- 7.2.2. Hypothyroidism
- 7.2.3. Male hypogonadism
- 7.2.4. Growth hormone deficiency
- 7.3. Market Analysis, Insights and Forecast – By Route of Administration
- 7.3.1. Oral
- 7.3.2. Transdermal
- 7.3.3. Parenteral
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospitals Pharmacies
- 7.4.2. Retail Pharmacies & Drug Stores
- 7.4.3. Online Pharmacies
- 7.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Therapy Type
- 8.1.1. Estrogen and Combinations Replacement Therapy
- 8.1.2. Thyroid Hormone Replacement Therapy
- 8.1.3. Growth Hormone Replacement Therapy
- 8.1.4. Testosterone Hormone Replacement Therapy
- 8.2. Market Analysis, Insights and Forecast – By Indication
- 8.2.1. Menopause
- 8.2.2. Hypothyroidism
- 8.2.3. Male hypogonadism
- 8.2.4. Growth hormone deficiency
- 8.3. Market Analysis, Insights and Forecast – By Route of Administration
- 8.3.1. Oral
- 8.3.2. Transdermal
- 8.3.3. Parenteral
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospitals Pharmacies
- 8.4.2. Retail Pharmacies & Drug Stores
- 8.4.3. Online Pharmacies
- 8.5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Therapy Type
- 9.1.1. Estrogen and Combinations Replacement Therapy
- 9.1.2. Thyroid Hormone Replacement Therapy
- 9.1.3. Growth Hormone Replacement Therapy
- 9.1.4. Testosterone Hormone Replacement Therapy
- 9.2. Market Analysis, Insights and Forecast – By Indication
- 9.2.1. Menopause
- 9.2.2. Hypothyroidism
- 9.2.3. Male hypogonadism
- 9.2.4. Growth hormone deficiency
- 9.3. Market Analysis, Insights and Forecast – By Route of Administration
- 9.3.1. Oral
- 9.3.2. Transdermal
- 9.3.3. Parenteral
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospitals Pharmacies
- 9.4.2. Retail Pharmacies & Drug Stores
- 9.4.3. Online Pharmacies
- 9.5. Market Analysis, Insights and Forecast – By Country/ sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Therapy Type
- 10.1.1. Estrogen and Combinations Replacement Therapy
- 10.1.2. Thyroid Hormone Replacement Therapy
- 10.1.3. Growth Hormone Replacement Therapy
- 10.1.4. Testosterone Hormone Replacement Therapy
- 10.2. Market Analysis, Insights and Forecast – By Indication
- 10.2.1. Menopause
- 10.2.2. Hypothyroidism
- 10.2.3. Male hypogonadism
- 10.2.4. Growth hormone deficiency
- 10.3. Market Analysis, Insights and Forecast – By Route of Administration
- 10.3.1. Oral
- 10.3.2. Transdermal
- 10.3.3. Parenteral
- 10.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.4.1. Hospitals Pharmacies
- 10.4.2. Retail Pharmacies & Drug Stores
- 10.4.3. Online Pharmacies
- 10.5. Market Analysis, Insights and Forecast – By Country/ sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Novo Nordisk A/S
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Pfizer Inc.
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. AbbVie Inc.
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Merck KGaA
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Endo Pharmaceuticals Solutions Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Allergan
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. Eli Lilly and Company
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. Mithra Pharmaceuticals
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Amgen
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook